tiprankstipranks

Keros Therapeutics to host conference call

Conference call to provide an overview of TROPOS, its global Phase 2 Clinical Trial to evaluate KER-012 in combination with background therapy in patients with Pulmonary Arterial Hypertension will be held on August 8 at 8 am. Webcast Link

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on KROS:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue